Library Design-Facilitated High-Throughput Sequencing of Synthetic Peptide Libraries

peer-reviewed · ACS Combinatorial Science · 2017

peer-reviewed · ACS Combinatorial Science · 2017. Alexander A. Vinogradov et al. A methodology to achieve high-throughput de novo sequencing of synthetic peptide mixtures is reported. The…
Date 2017-11-13
Type peer-reviewed
Venue ACS Combinatorial Science
Publisher American Chemical Society (ACS)
Contribution adjacent
DOI 10.1021/acscombsci.7b00109
Citations (OpenAlex) 46

Abstract

A methodology to achieve high-throughput de novo sequencing of synthetic peptide mixtures is reported. The approach leverages shotgun nanoliquid chromatography coupled with tandem mass spectrometry-based de novo sequencing of library mixtures (up to 2000 peptides) as well as automated data analysis protocols to filter away incorrect assignments, noise, and synthetic side-products. For increasing the confidence in the sequencing results, mass spectrometry-friendly library designs were developed that enabled unambiguous decoding of up to 600 peptide sequences per hour while maintaining greater than 85% sequence identification rates in most cases. The reliability of the reported decoding strategy was additionally confirmed by matching fragmentation spectra for select authentic peptides identified from library sequencing samples. The methods reported here are directly applicable to screening techniques that yield mixtures of active compounds, including particle sorting of one-bead one-compound libraries and affinity enrichment of synthetic library mixtures performed in solution.

Authors

  1. Alexander A. Vinogradov · Massachusetts Institute of Technology
  2. Zachary P. Gates · Agency for Science, Technology and Research, Institute of Chemical and Engineering Sciences, Institute of Molecular and Cell Biology, Massachusetts Institute of Technology
  3. Chi Zhang · Massachusetts Institute of Technology
  4. Anthony J. Quartararo · FogPharma (United States), Massachusetts Institute of Technology
  5. Kathryn H. Halloran · Massachusetts Institute of Technology
  6. Bradley L. Pentelute · Broad Institute, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology

Methods and tools

Methods it uses

  • PEAKS: Commercial DP-based de novo

Seen in the charts

Back to the full map

Back to top